ethnic minorities

News

Access to a stem cell transplant in the US - and the chances of surviving it - depends on social and economic factors, finds a new study.

Partner Content

Partner Content

New research shows how to improve trial diversity

News

Viridian has fired a shot across Amgen's bows with the FDA approval of Tepezza rival Lumvoa in thyroid eye disease, a $2bn market.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.